These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 31186061)

  • 1. The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review.
    Zhou J; Yi Q; Tang L
    J Exp Clin Cancer Res; 2019 Jun; 38(1):250. PubMed ID: 31186061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal adhesion kinase as a cancer therapy target.
    Golubovskaya VM
    Anticancer Agents Med Chem; 2010 Dec; 10(10):735-41. PubMed ID: 21214510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear FAK: a new mode of gene regulation from cellular adhesions.
    Lim ST
    Mol Cells; 2013 Jul; 36(1):1-6. PubMed ID: 23686429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal adhesion kinase signaling - tumor vulnerabilities and clinical opportunities.
    Schlaepfer DD; Ojalill M; Stupack DG
    J Cell Sci; 2024 Jul; 137(14):. PubMed ID: 39034922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of FAK in tumor metabolism and therapy.
    Zhang J; Hochwald SN
    Pharmacol Ther; 2014 May; 142(2):154-63. PubMed ID: 24333503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights.
    Yoon H; Dehart JP; Murphy JM; Lim ST
    J Histochem Cytochem; 2015 Feb; 63(2):114-28. PubMed ID: 25380750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth.
    Tancioni I; Miller NL; Uryu S; Lawson C; Jean C; Chen XL; Kleinschmidt EG; Schlaepfer DD
    Breast Cancer Res; 2015 Mar; 17():47. PubMed ID: 25880415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of focal adhesion kinase inhibitors in cancer therapy.
    Ma WW
    Anticancer Agents Med Chem; 2011 Sep; 11(7):638-42. PubMed ID: 21787276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal adhesion kinase: a potential target in cancer therapy.
    van Nimwegen MJ; van de Water B
    Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAK inhibitors in Cancer, a patent review.
    Lv PC; Jiang AQ; Zhang WM; Zhu HL
    Expert Opin Ther Pat; 2018 Feb; 28(2):139-145. PubMed ID: 29210300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Insights on the Nuclear Functions and Targeting of FAK in Cancer.
    Pomella S; Cassandri M; Braghini MR; Marampon F; Alisi A; Rota R
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal adhesion kinase and p53 signal transduction pathways in cancer.
    Golubovskaya VM; Cance W
    Front Biosci (Landmark Ed); 2010 Jun; 15(3):901-12. PubMed ID: 20515733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal adhesion kinase-An emerging viable target in cancer and development of focal adhesion kinase inhibitors.
    Chauhan A; Khan T
    Chem Biol Drug Des; 2021 Mar; 97(3):774-794. PubMed ID: 33191630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors.
    Marlowe TA; Lenzo FL; Figel SA; Grapes AT; Cance WG
    Mol Cancer Ther; 2016 Dec; 15(12):3028-3039. PubMed ID: 27638858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pathways: Endothelial Cell FAK-A Target for Cancer Treatment.
    Roy-Luzarraga M; Hodivala-Dilke K
    Clin Cancer Res; 2016 Aug; 22(15):3718-24. PubMed ID: 27262114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy.
    Pang XJ; Liu XJ; Liu Y; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Song J; Jin CY; Zhang SY
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.
    Shanthi E; Krishna MH; Arunesh GM; Venkateswara Reddy K; Sooriya Kumar J; Viswanadhan VN
    Expert Opin Ther Pat; 2014 Oct; 24(10):1077-100. PubMed ID: 25113248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAK signaling in human cancer as a target for therapeutics.
    Lee BY; Timpson P; Horvath LG; Daly RJ
    Pharmacol Ther; 2015 Feb; 146():132-49. PubMed ID: 25316657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal adhesion kinase as potential target for cancer therapy (Review).
    Hao H; Naomoto Y; Bao X; Watanabe N; Sakurama K; Noma K; Motoki T; Tomono Y; Fukazawa T; Shirakawa Y; Yamatsuji T; Matsuoka J; Wang ZG; Takaoka M
    Oncol Rep; 2009 Nov; 22(5):973-9. PubMed ID: 19787209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders.
    Yang M; Xiang H; Luo G
    Biochem Pharmacol; 2024 Jun; 224():116246. PubMed ID: 38685282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.